Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Cutlip, S. Windecker, R. Mehran, A. Boam, D. Cohen, G. Es, P. Steg, M. Morel, L. Mauri, P. Vranckx, E. Mcfadden, A. Lansky, M. Hamon, M. Krucoff, P. Serruys (2007)
Clinical End Points in Coronary Stent Trials: A Case for Standardized DefinitionsCirculation, 115
J. Moses, R. Mehran, E. Nikolsky, J. Lasala, Woodrow Corey, G. Albin, C. Hirsch, M. Leon, M. Russell, S. Ellis, G. Stone (2005)
Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.Journal of the American College of Cardiology, 45 8
L. Mauri, Wen-hua Hsieh, J. Massaro, K. Ho, R. D'Agostino, D. Cutlip (2007)
Stent thrombosis in randomized clinical trials of drug-eluting stents.The New England journal of medicine, 356 10
Meaghan Beattie, Michael Lee (2010)
Safety and efficacy of drug-eluting stents compared with bare metal stents in ST-elevation myocardial infarction.Reviews in cardiovascular medicine, 11 2
R. Kerensky, M. Wade, P. Deedwania, W. Boden, C. Pepine (2002)
Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory.Journal of the American College of Cardiology, 39 9
Ik-Kyung Jang, Herman Gold, A. Ziskind, John Fallon, R. Holt, R. Leinbach, James May, D. Collen (1989)
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.Circulation, 79 4
Anderson (2007)
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency MedicineJ Am Coll Cardiol, 50
K. Harjai, C. Shenoy, Pamela Orshaw, J. Boura (2009)
Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the Guthrie PCI RegistryHeart, 95
U. Stenestrand, S. James, J. Lindbäck, Ole Fröbert, J. Carlsson, F. Scherstén, T. Nilsson, B. Lagerqvist (2010)
Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).European heart journal, 31 2
G. Wong, D. Morrow, Sean Murphy, Nicole Kraimer, R. Pai, D. James, D. Robertson, L. Demopoulos, Peter Dibattiste, C. Cannon, C. Gibson (2002)
Elevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion: A TACTICS-TIMI 18 SubstudyCirculation: Journal of the American Heart Association, 106
C. Grines, Robert Bonow, Donald Casey, Timothy Gardner, Peter Lockhart, D. Moliterno, Patrick O'Gara, Patrick Whitlow (2007)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American DCirculation, 115 6
M. Morice, P. Serruys, J. Sousa, J. Fajadet, E.Ban Hayashi, M. Perin, A. Colombo, G. Schuler, P. Barragan, G. Guagliumi, F. Molnár, R. Falotico (2002)
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.The New England journal of medicine, 346 23
G. Stone, S. Ellis, D. Cox, J. Hermiller, C. O'shaughnessy, J. Mann, M. Turco, R. Caputo, P. Bergin, Joel Greenberg, J. Popma, M. Russell (2004)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.The New England journal of medicine, 350 3
K. Harjai, Pamela Orshaw, C. Shenoy, S. Acharji, D. Sporn, Ali Aboufares, D. Stapleton (2008)
Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).Journal of interventional cardiology, 21 4
J. Moses, M. Leon, J. Popma, P. Fitzgerald, D. Holmes, C. O'shaughnessy, R. Caputo, D. Kereiakes, David Williams, P. Teirstein, Judith Jaeger, R. Kuntz (2003)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.The New England journal of medicine, 349 14
M. Joner, A. Finn, A. Farb, E. Mont, F. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. Gold, R. Virmani (2006)
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.Journal of the American College of Cardiology, 48 1
C. Stettler, Simon Wandel, S. Allemann, A. Kastrati, M. Morice, A. Schömig, M. Pfisterer, G. Stone, M. Leon, J. Lezo, J. Goy, Seung‐Jung Park, M. Sabaté, M. Suttorp, H. Kelbaek, C. Spaulding, M. Menichelli, P. Vermeersch, M. Dirksen, P. Červinka, A. Petronio, A. Nordmann, P. Diem, B. Meier, M. Zwahlen, S. Reichenbach, S. Trelle, S. Windecker, P. Jüni (2007)
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisThe Lancet, 370
K. Mizuno, K. Satomura, A. Miyamoto, K. Arakawa, T. Shibuya, T. Arai, A. Kurita, H. Nakamura, J. Ambrose (1992)
Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes.The New England journal of medicine, 326 5
M. Hill, I. Rosenwaike (2001)
The Social Security Administration's Death Master File: the completeness of death reporting at older ages.Social security bulletin, 64 1
Somjot Brar, M. Leon, G. Stone, R. Mehran, J. Moses, Simerjeet Brar, G. Dangas (2009)
Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis.Journal of the American College of Cardiology, 53 18
S. James, U. Stenestrand, J. Lindbäck, J. Carlsson, F. Scherstén, T. Nilsson, L. Wallentin, B. Lagerqvist (2009)
Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.The New England journal of medicine, 360 19
J. Goldstein, D. Demetriou, C. Grines, M. Pica, M. Shoukfeh, W. O’Neill (2000)
Multiple complex coronary plaques in patients with acute myocardial infarction.The New England journal of medicine, 343 13
D. Kandzari, M. Roe, E. Ohman, Sarah Milford-Beland, A. Chen, B. Lytle, D. Cohen, Sidney Smith, R. Harrington, W. Gibler, E. Peterson (2005)
Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.The American journal of cardiology, 96 6
A. Kirtane, Anuj Gupta, S. Iyengar, J. Moses, M. Leon, R. Applegate, B. Brodie, E. Hannan, K. Harjai, L. Jensen, Seung‐Jung Park, R. Perry, Michael Racz, F. Saia, J. Tu, R. Waksman, A. Lansky, R. Mehran, G. Stone (2009)
Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational StudiesCirculation, 119
J. Tu, J. Bowen, M. Chiu, D. Ko, P. Austin, Yaohua He, R. Hopkins, J. Tarride, G. Blackhouse, C. Lazzam, E. Cohen, R. Goeree (2007)
Effectiveness and safety of drug-eluting stents in Ontario.The New England journal of medicine, 357 14
P. Liebson, Lloyd Klein (1997)
The non-Q wave myocardial infarction revisited: 10 years later.Progress in cardiovascular diseases, 39 5
T. Lüscher, J. Steffel, F. Eberli, M. Joner, G. Nakazawa, F. Tanner, R. Virmani (2007)
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical ImplicationsCirculation, 115
L. Mauri, Treacy Silbaugh, Pallav Garg, R. Wolf, Katya Zelevinsky, Ann Lovett, Manu Varma, Zheng Zhou, S. Normand (2008)
Drug-eluting or bare-metal stents for acute myocardial infarction.The New England journal of medicine, 359 13
Background: The long‐term safety and effectiveness of drug‐eluting stents (DES) versus bare metal stents (BMS) in non‐ST‐segment elevation myocardial infarction (NSTEMI) beyond 2 years after percutaneous coronary intervention (PCI) is unknown. Methods: We studied 674 NSTEMI patients who underwent successful PCI with DES (n = 323) or BMS (n = 351). The primary study end‐points were time to occurrence of death or nonfatal recurrent myocardial infarction (MI), and stent thrombosis (ST). Secondary end‐points included time to occurrence of target vessel revascularization (TVR) and any major adverse cardiovascular event (MACE, defined as the composite of death, MI, ST, TVR). Results: The DES and BMS groups were well matched except that DES patients received dual antiplatelet therapy for a longer duration and had smaller final vessel diameter. In survival analysis, at a mean follow‐up of 1333 ± 659 days after PCI, the DES group had similar incidence of death/myocardial infarction (24% vs. 27%, log rank p = 0.23) and ST (4.0% vs. 2.6%, p = 0.18) as the BMS group. The DES patients had lower incidence of TVR (8.1% vs. 17%, p = 0.0018) but similar MACE (26% vs. 37%, p = 0.31). In multivariable analysis, DES vs. BMS implantation showed no significant impact on death/myocardial infarction (adjusted hazards ratio (HR) 1.0, 95% confidence intervals (CI) 0.7–1.4), ST (HR 1.7; CI 0.7 – 4.0), or MACE (HR 0.8; CI 0.6 – 1.1). However, TVR was lower in the DES group (HR 0.4; CI 0.3 – 0.7). Conclusion: In patients presenting with NSTEMI, DES implantation appears to be as safe as BMS implantation at long‐term follow‐up. In addition, DES are effective in reducing TVR compared to BMS. (J Interven Cardiol 2012;25:28–36)
Journal of Interventional Cardiology – Wiley
Published: Feb 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.